Ten-year relative suvival for ovarian cancer. Background: When GOG 172 showed a benefit to intraperitoneal (IP) chemotherapy as frontline treatment for advanced ovarian cancer, our division adopted IP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback